Drug intelligence / Profile preview

Canady Helios Cold Plasma

Development stage
Unknown
Lead developer
US Medical Innovations
Administration
Intraoperative
01

Overview

Canady Helios Cold Plasma (CHCP) is a medical device that delivers non-thermal (room temperature) cold atmospheric plasma (CAP) and an electromagnetic field to target cancer cells. The system generates reactive oxygen species (ROS), reactive nitrogen species (RNS), and a specific electromagnetic field called the Plasma Treatment Electromagnetic Field (PTEF). These components selectively disrupt cellular homeostasis in cancer cells, leading to cell cycle interruption, reduced viability, and apoptosis without damaging normal tissue. The technology is primarily used as an adjuvant therapy after surgical removal of solid tumors to eliminate microscopic residual cancer cells at the margins[1][2][8].

Brand names
Canady Helios Cold PlasmaCanady Helios Cold Plasma ScalpelCanady Helios Cold Plasma Ablation System
Other names
cold atmospheric plasma devicecold plasma scalpel

Beyond the preview

Go deeper on Canady Helios Cold Plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canady Helios Cold Plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call